Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Blood (2013) 122 (21): 546.

https://doi.org/10.1182/blood.V122.21.546.546

Published: 2013

Journal Articles

Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors

Farid Boulad, MD, Stella M. Davies, MBBS, PhD, David A. Williams, MD, David A Margolis, MD, Elizabeth G Klein, Leslie E. Lehmann, MD, Christine Duncan, MD, MMSc, Eva C. Guinan, MD, Parinda A. Mehta

Blood (2012) 120 (21): 3471.

https://doi.org/10.1182/blood.V120.21.3471.3471

Published: 2012

Journal Articles

A Novel Chemotherapy-Based Allogeneic Hematopoietic Stem Cell Transplant Regimen for Very Young Children with Leukemia.

Susan E. Prockop, MD, Nancy A. Kernan, MD, Elizabeth G Klein, Rachel Kobos, MD, Andromachi Scaradavou, MD, Trudy N. Small, MD, Richard J. O'Reilly, MD, Farid Boulad, MD

Blood (2012) 120 (21): 3149.

https://doi.org/10.1182/blood.V120.21.3149.3149

Published: 2012

Journal Articles

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Farid Boulad, MD, Guenther Koehne, MD, PhD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Trudy N. Small, MD, Andromachi Scaradavou, MD, Miguel-Angel Perales, MD, Hugo R Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Jenna D Goldberg, MD, Elizabeth G Klein, Rachel Kobos, MD, Ann A. Jakubowski, MD, PhD, Doris Ponce, MD, Juliet Barker, MBBS, James W. Young, MD, Craig S. Sauter, MD, Sergio Giralt, MD, Richard J. O'Reilly, MD

Blood (2012) 120 (21): 3144.

https://doi.org/10.1182/blood.V120.21.3144.3144

Published: 2012

Journal Articles

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Farid Boulad, MD, Nancy A Kernan, MD, Susan E Prockop, MD, Andromachi Scaradavou, MD, Trudy N Small, M.D, Elizabeth G Klein, Juliet Barker, MBBS, (Hons), FRACP, Ann A. Jakubowski, MD, PhD, Guenther Koehne, MD, Esperanza Papadopoulos, MD, Miguel-Angel Perales, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 2354.

https://doi.org/10.1182/blood.V116.21.2354.2354

Published: 2010

NARROW

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors

A Novel Chemotherapy-Based Allogeneic Hematopoietic Stem Cell Transplant Regimen for Very Young Children with Leukemia.

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors

A Novel Chemotherapy-Based Allogeneic Hematopoietic Stem Cell Transplant Regimen for Very Young Children with Leukemia.

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only